Form D · Pharmaceuticals
PeptiMed, Inc.
Jefferson, WI · CIK 0001678032
Offering snapshot reported Jun 23, 2016 · SEC filing
- Reported sold
- $200K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jun 10, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2016 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-265646
The total offering amount of $500,000 has been committed for sale to a single investor, of which the investor paid $200,000 on the date of first sale and will pay the remaining amount owing in installments ending on June 1, 2017.
Source: Form D, filed Jun 23, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Primiano | Director, Promoter |
| Nicholas Primiano | Director, Promoter |
| Scott Schneider | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
N5485 Harvey Road
Jefferson, WI, 53549
Jefferson, WI, 53549